We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » ICH Guidance Urges Use of Risk Assessments for CQAs
ICH Guidance Urges Use of Risk Assessments for CQAs
July 8, 2011
Drugmakers should use risk assessments to identify material attributes and manufacturing process parameters that may affect a drug’s critical quality attributes (CQAs), a draft International Conference on Harmonisation (ICH) guidance says.